GHK-Cu and the reconstitution argument. Half the threads on this are arguing past each other about arithmetic.
Two weeks is not enough time to attribute anything to a compound unless the effect is dramatic.
Vivid dreams and mild headache for the first 5 days, then nothing. Textbook for this class, apparently.
What surprised me is how much of the perceived benefit was routine and attention rather than pharmacology.
My rule now: if a claim cannot survive being written down with the numbers attached, it is marketing.
What would change your mind about this?
This board overrates bloodwork. A number moving is not the outcome you wanted.
This is the kind of post the forum exists for. Same for me with GHK-Cu, unfortunately.
Same here.
Narrow conclusion, briefly right. Broad conclusion, interestingly wrong. I know which I keep choosing.
Narrow conclusion, briefly right. Broad conclusion, interestingly wrong. I know which I keep choosing.
Baseline first.
Narrow conclusion. Not on GHK-Cu but the pattern is familiar.
Same here.
Injection site reaction was my main issue with GHK-Cu too.
An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison. Same for me with GHK-Cu, unfortunately.
Most of the popular protocol is borrowed from a clinical population and applied to healthy people without comment.
Baseline first. Injection site reaction was my main issue with GHK-Cu too.
Read methods.
Baseline first.
A certificate of analysis answers one question and gets quoted as though it answers four.